Additional file 1 of Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment

Additional file 1: Table S1. Summary of Study Characteristics. Table S2. PD-L1: OS and PFS Data in NSCLC. Table S3. PD-L1 and TMB: OS and PFS Data in NSCLC. Table S4. PD-L1: OS and PFS Data in Melanoma